The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms
Pharma major reports FY26 revenue of Rs 9,204 crore with 16.6% growth
The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty
The kidney care provider has established over 40 dialysis centres, delivering more than 40,000 dialysis sessions
The company has also launched Elyara, a portfolio of products in regenerative medical aesthetics focused on non-invasive skin and hair restoration
The company secured new accounts, including ACCESS-PVI trial sites, and aims to strengthen global commercialization efforts
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
Funds to support product expansion, quick commerce growth, and manufacturing scale-up for holistic period care solutions
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
